FDA Alerts

The FDA has approved a generic option for the treatment of patients with relapsing forms of multiple sclerosis. For details, including dosage and common adverse effects, read more.

The FDA has approved a new option for glycemic control in adults with type 1 and type 2 diabetes. For details, including dosing and adverse events, read more.

The US Food and Drug Administration has approved a new continuous glucose monitoring system for adult patients with diabetes.

The US Food and Drug Administration (FDA) has indicated nivolumab for intravenous use in patients with previously treated liver cancer.

The US Food and Drug Administration (FDA) expanded the approval of a targeted therapy to treat gastric or gastroesophageal junction (GEJ) cancer.

The US Food and Drug Administration recently approved the first single dose once-daily inhaler to be used as maintenance therapy for patients with chronic obstructive pulmonary disease.

The US Food and Drug Administration has approved a new option for the treatment of bacterial vaginosis in adult women.

The US Food and Drug Administration has approved a generic oral suspension of a common influenza drug to prevent and treat the virus in adults and children.

The FDA has approved new indication for 2 previously-approved treatment option for partial-onset seizures.

The FDA has approved the first treatment option in the United States for patients age 3 years or older with congenital or idiopathic pulmonary arterial hypertension.